STANDARD BIOTOOLS INC. (LAB) Options Statistics & Positioning

Max pain sits at $0.5 and the put/call open interest ratio is 0.00. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$0.65
52-week range
$0.64 – $1.69
IV rank
100 / 100
High
Put/call OI
0.00
Call-heavy
Max pain
$0.5
↓ 23.1% below close
Next earnings
Oct 11, 2026

Explore LAB Options Statistics

Upcoming Earnings

LAB's next expected earnings date is Oct 11, 2026.

Explore the payoff profile of option on LAB for free

Build multi-leg LAB strategies, visualize payoffs, and scan the full US options universe with OptiView.

LAB Options FAQ

When is LAB's next earnings date?

LAB's next expected earnings date is Oct 11, 2026.

How often is LAB options data on this page updated?

All LAB statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see LAB max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated LAB pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.